Although, other studies suggest a direct cytotoxic anticancer activity of the neutrophil defensins [29,35,36], our results suggest a possible immune–stimulatory effect of neutrophil defensin 1, 2 and 3 towards lung cancer. This evidence concerns the gene DEFA1 and lung carcinoma.